Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
© 2015 The Author 2015. Background. The approved tenofovir disoproxil fumarate (TDF) dose of 300 mg every 48 hours for adults with moderate renal impairment is often confusing and inconvenient. Using a new TDF formulation, we compared the pharmacokinetics of the standard dose with a dose of 150 mg o...
Saved in:
Main Authors: | Tim R. Cressey, Anchalee Avihingsanon, Guttiga Halue, Prattana Leenasirimakul, Pra Ornsuda Sukrakanchana, Yardpiroon Tawon, Nirattiya Jaisieng, Gonzague Jourdain, Anthony T. Podany, Courtney V. Fletcher, Virat Klinbuayaem, Chureeratana Bowonwatanuwong |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84938634555&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54814 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Plasma and Intracellular Pharmacokinetics of Tenofovir Disoproxil Fumarate 300 mg Every 48 Hours vs 150 mg Once Daily in HIV-Infected Adults with Moderate Renal Function Impairment
by: Tim R. Cressey, et al.
Published: (2018) -
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020) -
Long term renal function in Asian HIV-1 infected adults receiving tenofovir disoproxil fumarate without protease inhibitors
by: Geoffroy Liegeon, et al.
Published: (2019) -
Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
by: David V. Glidden, et al.
Published: (2018) -
Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Temofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Temofovir Disoproxil Fumarate Monotherapy
by: Vera E. Bukkems, et al.
Published: (2020)